Search Results 321-330 of 16359 for monoclonal antibody

  1. Mayo Clinic Podcast - Dr. Greg Poland - 4 12 21 - YouTube Au...

    COVID-19 using monoclonal antibodies. And I'm wondering, why would we do that when. D. D. D. D. Mayo Clinic Podcast - Dr. Greg Poland - 4 12Page 9 of 12.

  2. Melanoma Clinical Trials - Mayo Clinic Research

    Monoclonal antibodies, such as atezolizumab, may interfere with the ability of tumor cells to grow and spread. Giving vemurafenib, cobimetinib, and ...

  3. Expertise in defining and treating neuromyelitis optica spectrum disease - Mayo Clinic

    Three monoclonal antibody therapies — eculizumab, inebilizumab and satralizumab — have been approved for adults with NMOSD and AQP4-IgG autoantibodies.

  4. Wilms Tumor Clinical Trials - Mayo Clinic Research

    Antibody-drug conjugates, such as lorvotuzumab mertansine, are ... Monoclonal antibodies, such as cixutumumab, can block tumor growth in different ways.

  5. Hematology - Clinical trials - Mayo Clinic

    ... monoclonal antibody, and compare them with clinical outcomes. Tissue and ... The purpose of this study is to evaluate the immune and hematopoietic compartments in ...

  6. Mayo Clinic expert offers perspective on experimental Alzheimer's disease drug

    A monoclonal antibody, lecanemab shows promise in removing amyloid plaques from the brain. Plaques are one of the defining features of Alzheimer's disease ...

  7. Publications - Jennifer B. Cowart, M.D. - Mayo Clinic

    ... Monoclonal Antibody Screening Score. Mayo Clin Proc Innov Qual Outcomes. 2023 Apr; 7 (2):109-121 Epub 2023 Jan 11. View PubMed; Cortes MP, Schultz CS, Isha S ...

  8. Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer - Mayo Clinic

    Monoclonal antibodies, such as ... No prior treatment with an immune checkpoint inhibitor (anti-PD-1, anti-PD-L1, anti-CTLA4 monoclonal antibody).

  9. Mayo Clinic Q & A - Dr. Gregory Poland - COVID-19 Update - ...

    In other words, people getting an injection of monoclonal antibodies and being protected for the next 90 plus days. Dr. Halena Gazelka 19:52. How interesting.

  10. Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma - Mayo Clinic

    Monoclonal antibodies, such as cixutumumab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find ...